Isotretinoína (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Isotretinoína" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

48nih.gov

4^th place

8^th place

45doi.org

2^nd place

4^th place

6web.archive.org

1^st place

4harvard.edu

18^th place

51^st place

4drugs.com

399^th place

289^th place

3medicines.org.uk

3,823^rd place

5,376^th place

3europa.eu

68^th place

56^th place

2clincalc.com

3,912^th place

low place

2zenodo.org

621^st place

1,847^th place

2jstor.org

26^th place

65^th place

2washingtonpost.com

34^th place

86^th place

2fda.gov

447^th place

869^th place

1books.google.com

3^rd place

6^th place

1medscape.com

719^th place

598^th place

1ipledgeprogram.com

low place

1australiandoctor.com.au

low place

1medsafe.govt.nz

low place

1contemporarypediatrics.com

low place

1escholarship.org

1,523^rd place

3,490^th place

1publishing.service.gov.uk

1,877^th place

5,756^th place

1consultaremedios.com.br

low place

3,423^rd place

1mhra.gov.uk

low place

1uminho.pt

low place

823^rd place

1medconnect.com.au

low place

1auth.gr

9,852^nd place

low place

1bjgp.org

low place

1nytimes.com

7^th place

14^th place

1cdc.gov

218^th place

177^th place

1latimes.com

22^nd place

60^th place

1gene.com

low place

1bloomberg.com

99^th place

191^st place

1pharmalive.com

low place

australiandoctor.com.au

«Fresh call for GPs to prescribe Roaccutane». AustralianDoctor. 19 de junho de 2012. Consultado em 7 de fevereiro de 2014. Cópia arquivada em 12 de abril de 2017

auth.gr

invenio.lib.auth.gr

(em grego). [S.l.]: Aristotle University of Thessaloniki. 2007 http://invenio.lib.auth.gr/record/103970 Em falta ou vazio |título= (ajuda)

bjgp.org

Magin P, Pond D, Smith W (fevereiro de 2005). «Isotretinoin, depression and suicide: a review of the evidence». The British Journal of General Practice (em inglês). 55 (511): 134–8. PMC 1463189. PMID 15720936

bloomberg.com

«Roche Accutane Acne Drug Caused 'Tragedy' for Actor, Brian Dennehy Says». Bloomberg. 11 de março de 2011

books.google.com

Analogue-based Drug Discovery. [S.l.]: John Wiley & Sons. 2006. ISBN 978-3-527-60749-5

cdc.gov

Centers for Disease Control Prevention (CDC) (janeiro de 2000). «Accutane-exposed pregnancies--California, 1999» (PDF). MMWR. Morbidity and Mortality Weekly Report. 49 (2): 28–31. PMID 10680601

clincalc.com

«The Top 300 of 2020». ClinCalc. Consultado em 7 de outubro de 2022
«Isotretinoin - Drug Usage Statistics». ClinCalc. Consultado em 7 de outubro de 2022

consultaremedios.com.br

consultaremedios.com.br. «Isotretinoína Ranbaxy com menor preço e entrega rápida, compre online | CR». Consulta Remédios. Consultado em 7 de fevereiro de 2023

contemporarypediatrics.com

«Isotretinoin risks in acne treatment: Page 3 of 4». Outubro de 2014

doi.org

dx.doi.org

Merritt B, Burkhart CN, Morrell DS (junho de 2009). «Use of isotretinoin for acne vulgaris». Pediatric Annals. 38 (6): 311–20. PMID 19588674. doi:10.3928/00904481-20090512-01
Layton A (maio de 2009). «The use of isotretinoin in acne». Dermato-Endocrinology. 1 (3): 162–9. PMC 2835909. PMID 20436884. doi:10.4161/derm.1.3.9364
Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R (abril de 2007). «Guidelines of care for acne vulgaris management». Journal of the American Academy of Dermatology. 56 (4): 651–63. PMID 17276540. doi:10.1016/j.jaad.2006.08.048
Georgala S, Katoulis AC, Georgala C, Bozi E, Mortakis A (junho de 2004). «Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: a randomised placebo controlled trial». Sexually Transmitted Infections. 80 (3): 216–8. PMC 1744851. PMID 15170007. doi:10.1136/sti.2003.006841
Sehgal VN, Srivastava G, Sardana K (junho de 2006). «Isotretinoin--unapproved indications/uses and dosage: a physician's reference». International Journal of Dermatology. 45 (6): 772–7. PMID 16796650. doi:10.1111/j.1365-4632.2006.02830.x
Choi JS, Koren G, Nulman I (março de 2013). «Pregnancy and isotretinoin therapy». Canadian Medical Association Journal. 185 (5): 411–3. PMC 3602257. PMID 23296582. doi:10.1503/cmaj.120729
Thiboutot DM, Cockerell CJ (agosto de 2006). «iPLEDGE: A Report from the Front Lines of Dermatologic Practice». The Virtual Mentor. 8 (8): 524–528. PMID 23234692. doi:10.1001/virtualmentor.2006.8.8.pfor1-0608
James M (junho de 1996). «Isotretinoin for severe acne». Lancet. 347 (9017): 1749–50. PMID 8656912. doi:10.1016/S0140-6736(96)90814-4
David M, Hodak E, Lowe NJ (1988). «Adverse effects of retinoids». Medical Toxicology and Adverse Drug Experience. 3 (4): 273–88. PMID 3054426. doi:10.1007/bf03259940
DiGiovanna JJ (novembro de 2001). «Isotretinoin effects on bone». Journal of the American Academy of Dermatology. 45 (5): S176-82. PMID 11606950. doi:10.1067/mjd.2001.113721
Ellis CN, Madison KC, Pennes DR, Martel W, Voorhees JJ (1984). «Isotretinoin therapy is associated with early skeletal radiographic changes». Journal of the American Academy of Dermatology. 10 (6): 1024–9. PMID 6588057. doi:10.1016/S0190-9622(84)80329-1
Moy A, McNamara NA, Lin MC (setembro de 2015). «Effects of Isotretinoin on Meibomian Glands». Optometry and Vision Science. 92 (9): 925–30. PMID 26154692. doi:10.1097/OPX.0000000000000656
Lambert RW, Smith RE (março de 1989). «Effects of 13-cis-retinoic acid on the hamster meibomian gland». The Journal of Investigative Dermatology. 92 (3): 321–5. PMID 2918239. doi:10.1111/1523-1747.ep12277122
Fraunfelder FT, Fraunfelder FW, Edwards R (setembro de 2001). «Ocular side effects possibly associated with isotretinoin usage». American Journal of Ophthalmology. 132 (3): 299–305. PMID 11530040. doi:10.1016/S0002-9394(01)01024-8
Brelsford M, Beute TC (setembro de 2008). «Preventing and managing the side effects of isotretinoin». Seminars in Cutaneous Medicine and Surgery. 27 (3): 197–206. PMID 18786498. doi:10.1016/j.sder.2008.07.002
Bremner JD, Shearer KD, McCaffery PJ (janeiro de 2012). «Retinoic acid and affective disorders: the evidence for an association». The Journal of Clinical Psychiatry (Systematic Review). 73 (1): 37–50. PMC 3276716. PMID 21903028. doi:10.4088/JCP.10r05993
Kontaxakis VP, Skourides D, Ferentinos P, Havaki-Kontaxaki BJ, Papadimitriou GN (janeiro de 2009). «Isotretinoin and psychopathology: a review». Annals of General Psychiatry. 8. 2 páginas. PMC 2637283. PMID 19154613. doi:10.1186/1744-859X-8-2
Borovaya A, Olisova O, Ruzicka T, Sárdy M (setembro de 2013). «Does isotretinoin therapy of acne cure or cause depression?». International Journal of Dermatology. 52 (9): 1040–52. PMID 23962262. doi:10.1111/ijd.12169
Goodfield MJ, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD (junho de 2010). «Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010». The British Journal of Dermatology. 162 (6): 1172–9. PMID 21250961. doi:10.1111/j.1365-2133.2010.09836.x
Ludot M, Mouchabac S, Ferreri F (junho de 2015). «Inter-relationships between isotretinoin treatment and psychiatric disorders: Depression, bipolar disorder, anxiety, psychosis and suicide risks». World Journal of Psychiatry. 5 (2): 222–7. PMC 4473493. PMID 26110123. doi:10.5498/wjp.v5.i2.222
Wysowski DK, Pitts M, Beitz J (outubro de 2001). «An analysis of reports of depression and suicide in patients treated with isotretinoin». Journal of the American Academy of Dermatology. 45 (4): 515–9. PMID 11568740. doi:10.1067/mjd.2001.117730
Rowe C, Spelman L, Oziemski M, Ryan A, Manoharan S, Wilson P, Daubney M, Scott J (maio de 2014). «Isotretinoin and mental health in adolescents: Australian consensus». The Australasian Journal of Dermatology (Review). 55 (2): 162–7. PMID 24283385. doi:10.1111/ajd.12117
Palha JA, Goodman AB (junho de 2006). «Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia» (PDF). Brain Research Reviews. 51 (1): 61–71. PMID 16325258. doi:10.1016/j.brainresrev.2005.10.001 |hdl-access= requer |hdl= (ajuda)
Goodman AB (março de 1994). «Retinoid dysregulation as a cause of schizophrenia». The American Journal of Psychiatry. 151 (3): 452–3. PMID 8109664. doi:10.1176/ajp.151.3.452b
Goodman AB (maio de 1996). «Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology». Schizophrenia Research. 19 (2–3): 163–70. PMID 8789914. doi:10.1016/0920-9964(96)88523-9
Goodman AB (julho de 2005). «Microarray results suggest altered transport and lowered synthesis of retinoic acid in schizophrenia». Molecular Psychiatry. 10 (7): 620–1. PMID 15838536. doi:10.1038/sj.mp.4001668
Samad TA, Krezel W, Chambon P, Borrelli E (dezembro de 1997). «Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family». Proceedings of the National Academy of Sciences of the United States of America. 94 (26): 14349–54. Bibcode:1997PNAS...9414349S. PMC 24972. PMID 9405615. doi:10.1073/pnas.94.26.14349
Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD (setembro de 2010). «Isotretinoin use and the risk of inflammatory bowel disease: a case-control study». The American Journal of Gastroenterology. 105 (9): 1986–93. PMC 3073620. PMID 20354506. doi:10.1038/ajg.2010.124
Lowenstein EB, Lowenstein EJ (2011). «Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero». Clinics in Dermatology. 29 (6): 652–61. PMID 22014987. doi:10.1016/j.clindermatol.2011.08.026
Kremer I, Gaton DD, David M, Gaton E, Shapiro A (1994). «Toxic effects of systemic retinoids on meibomian glands». Ophthalmic Research. 26 (2): 124–8. PMID 8196934. doi:10.1159/000267402
Griffin JN, Pinali D, Olds K, Lu N, Appleby L, Doan L, Lane MA (novembro de 2010). «13-Cis-retinoic acid decreases hypothalamic cell number in vitro». Neuroscience Research. 68 (3): 185–90. PMID 20708044. doi:10.1016/j.neures.2010.08.003
Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery P (abril de 2004). «13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice». Proceedings of the National Academy of Sciences of the United States of America. 101 (14): 5111–6. Bibcode:2004PNAS..101.5111C. JSTOR 3371827. PMC 387382. PMID 15051884. doi:10.1073/pnas.0306336101
Sakai Y, Crandall JE, Brodsky J, McCaffery P (junho de 2004). «13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice». Annals of the New York Academy of Sciences. 1021 (1): 436–40. Bibcode:2004NYASA1021..436S. PMID 15251924. doi:10.1196/annals.1308.059
Nelson AM, Cong Z, Gilliland KL, Thiboutot DM (setembro de 2011). «TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells». The British Journal of Dermatology. 165 (3): 526–33. PMC 3166444. PMID 21564055. doi:10.1111/j.1365-2133.2011.10392.x
Nelson AM, Gilliland KL, Cong Z, Thiboutot DM (outubro de 2006). «13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes». The Journal of Investigative Dermatology. 126 (10): 2178–89. PMID 16575387. doi:10.1038/sj.jid.5700289
Wachter K (2009). «Isotretinoin's Mechanism of Action Explored». Skin & Allergy News. 40 (11). 32 páginas. doi:10.1016/S0037-6337(09)70553-4
Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM (abril de 2008). «Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells». The Journal of Clinical Investigation. 118 (4): 1468–78. PMC 2262030. PMID 18317594. doi:10.1172/JCI33869
Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, Butkus D, Arnaud-Battandier J (fevereiro de 1979). «Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid». The New England Journal of Medicine. 300 (7): 329–33. PMID 153472. doi:10.1056/NEJM197902153000701
Shalita A (2001). «The integral role of topical and oral retinoids in the early treatment of acne». Journal of the European Academy of Dermatology and Venereology. 15: 43–9. PMID 11843233. doi:10.1046/j.0926-9959.2001.00012.x
Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E (junho de 2001). «Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation». Proceedings of the National Academy of Sciences of the United States of America. 98 (12): 6662–7. Bibcode:2001PNAS...98.6662P. JSTOR 3055868. PMC 34517. PMID 11371621. doi:10.1073/pnas.111464998
Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M (junho de 2002). «Sebaceous glands in acne patients express high levels of neutral endopeptidase». Experimental Dermatology. 11 (3): 241–7. PMID 12102663. doi:10.1034/j.1600-0625.2002.110307.x
Wysowski DK, Swartz L (maio de 2005). «Relationship between headache and depression in users of isotretinoin». Archives of Dermatology (em inglês). 141 (5): 640–1. PMID 15897395. doi:10.1001/archderm.141.5.640
Ng CH, Schweitzer I (fevereiro de 2003). «The association between depression and isotretinoin use in acne». The Australian and New Zealand Journal of Psychiatry (em inglês). 37 (1): 78–84. PMID 12534661. doi:10.1046/j.1440-1614.2003.01111.x
Choi JS, Koren G, Nulman I (março de 2013). «Pregnancy and isotretinoin therapy». CMAJ. 185 (5): 411–413. PMC 3602257. PMID 23296582. doi:10.1503/cmaj.120729
Halverstam CP, Zeichner J, Lebwohl M (2006). «Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature». Journal of Cutaneous Medicine and Surgery. 10 (6): 291–9. PMID 17241599. doi:10.2310/7750.2006.00065

drugs.com

«FDA information, side effects, and uses / Accutane (isotretinoin)». U. S. Food and Drug Administration (FDA). Consultado em 20 de janeiro de 2014
«FDA information, side effects, and uses / Accutane (isotretinoin) : Table 2 Pharmacokinetic Parameters of Isotretinoin Mean (%CV), N=74». U. S. Food and Drug Administration (FDA). Consultado em 20 de janeiro de 2014
«FDA information, side effects, and uses / Accutane (isotretinoin) : Drug Interactions». U. S. Food and Drug Administration (FDA). Consultado em 20 de janeiro de 2014
«Isotretinoin international brands». Drugs.com. Consultado em 1 de junho de 2017

escholarship.org

Moy A, McNamara NA, Lin MC (setembro de 2015). «Effects of Isotretinoin on Meibomian Glands». Optometry and Vision Science. 92 (9): 925–30. PMID 26154692. doi:10.1097/OPX.0000000000000656

europa.eu

ema.europa.eu

«Isotretinoin (oral formulations): CMDH scientific conclusions – Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s)» (PDF). European Medicines Agency. Agosto de 2017. Consultado em 17 de maio de 2019
«Pharmacovigilance Risk Assessment Committee (PRAC) – Minutes for the meeting on 3–6 July 2017» (PDF). European Medicines Agency. 1 de setembro de 2017. p. 44. Consultado em 17 de maio de 2019
«Updated measures for pregnancy prevention during retinoid use». European Medicines Agency. 21 de junho de 2018

fda.gov

accessdata.fda.gov

US Label (PDF) (Relatório). FDA. 22 de outubro de 2010 See FDA Index page for NDA 018662 for updates

fda.gov

«Isotretinoin (marketed as Accutane) Capsule Information». U.S. Food and Drug Administration (FDA). 3 de novembro de 2018

gene.com

«Roche Discontinues and Plans to Delist Accutane in the U.S.» (Nota de imprensa). Genentech. 29 de junho de 2009. Consultado em 12 de novembro de 2010. Arquivado do original em 8 de novembro de 2009

harvard.edu

ui.adsabs.harvard.edu

Samad TA, Krezel W, Chambon P, Borrelli E (dezembro de 1997). «Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family». Proceedings of the National Academy of Sciences of the United States of America. 94 (26): 14349–54. Bibcode:1997PNAS...9414349S. PMC 24972. PMID 9405615. doi:10.1073/pnas.94.26.14349
Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery P (abril de 2004). «13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice». Proceedings of the National Academy of Sciences of the United States of America. 101 (14): 5111–6. Bibcode:2004PNAS..101.5111C. JSTOR 3371827. PMC 387382. PMID 15051884. doi:10.1073/pnas.0306336101
Sakai Y, Crandall JE, Brodsky J, McCaffery P (junho de 2004). «13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice». Annals of the New York Academy of Sciences. 1021 (1): 436–40. Bibcode:2004NYASA1021..436S. PMID 15251924. doi:10.1196/annals.1308.059
Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E (junho de 2001). «Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation». Proceedings of the National Academy of Sciences of the United States of America. 98 (12): 6662–7. Bibcode:2001PNAS...98.6662P. JSTOR 3055868. PMC 34517. PMID 11371621. doi:10.1073/pnas.111464998

ipledgeprogram.com

«iPledge (About iPledge)». Consultado em 20 de fevereiro de 2011. Arquivado do original em 29 de julho de 2017

jstor.org

Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery P (abril de 2004). «13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice». Proceedings of the National Academy of Sciences of the United States of America. 101 (14): 5111–6. Bibcode:2004PNAS..101.5111C. JSTOR 3371827. PMC 387382. PMID 15051884. doi:10.1073/pnas.0306336101
Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E (junho de 2001). «Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation». Proceedings of the National Academy of Sciences of the United States of America. 98 (12): 6662–7. Bibcode:2001PNAS...98.6662P. JSTOR 3055868. PMC 34517. PMID 11371621. doi:10.1073/pnas.111464998

latimes.com

«New study may deal final blow to acne drug Accutane». Los Angeles Times. 7 de novembro de 2009

medconnect.com.au

«Isotretinoin's Mechanism of Action Elucidated». Medconnect. Elsevier Global Medical News. 28 de agosto de 2009. Consultado em 13 de novembro de 2010. Cópia arquivada em 4 de abril de 2010

medicines.org.uk

«Roaccutane 20mg Soft Capsules - Summary of Product Characteristics». UK Electronic Medicines Compendium. 1 de julho de 2015
«Isotretinoin 20mg capsules - - (eMC)». www.medicines.org.uk. Consultado em 27 de dezembro de 2017. Arquivado do original em 28 de dezembro de 2017
«Isotretinoin 20mg capsules - - (eMC)». www.medicines.org.uk. Consultado em 10 de janeiro de 2018. Arquivado do original em 28 de dezembro de 2017

medsafe.govt.nz

«Acne, Isotretinoin, and Depression». MEDSAFE (New Zealand Ministry of Health). Junho de 2013 [June 2005]. Consultado em 7 de fevereiro de 2014

medscape.com

«Dermatologists Frustrated With Problematic iPledge Program». Medscape. 9 de março de 2006

mhra.gov.uk

info.mhra.gov.uk

«Interactive Drug Analysis Profile - Isotretinoin». mhra.gov.uk. Medicines & Healthcare Products Regulatory Agency. 31 de março de 2017

nih.gov

ncbi.nlm.nih.gov

Merritt B, Burkhart CN, Morrell DS (junho de 2009). «Use of isotretinoin for acne vulgaris». Pediatric Annals. 38 (6): 311–20. PMID 19588674. doi:10.3928/00904481-20090512-01
Layton A (maio de 2009). «The use of isotretinoin in acne». Dermato-Endocrinology. 1 (3): 162–9. PMC 2835909. PMID 20436884. doi:10.4161/derm.1.3.9364
Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R (abril de 2007). «Guidelines of care for acne vulgaris management». Journal of the American Academy of Dermatology. 56 (4): 651–63. PMID 17276540. doi:10.1016/j.jaad.2006.08.048
Georgala S, Katoulis AC, Georgala C, Bozi E, Mortakis A (junho de 2004). «Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: a randomised placebo controlled trial». Sexually Transmitted Infections. 80 (3): 216–8. PMC 1744851. PMID 15170007. doi:10.1136/sti.2003.006841
Sehgal VN, Srivastava G, Sardana K (junho de 2006). «Isotretinoin--unapproved indications/uses and dosage: a physician's reference». International Journal of Dermatology. 45 (6): 772–7. PMID 16796650. doi:10.1111/j.1365-4632.2006.02830.x
Choi JS, Koren G, Nulman I (março de 2013). «Pregnancy and isotretinoin therapy». Canadian Medical Association Journal. 185 (5): 411–3. PMC 3602257. PMID 23296582. doi:10.1503/cmaj.120729
Thiboutot DM, Cockerell CJ (agosto de 2006). «iPLEDGE: A Report from the Front Lines of Dermatologic Practice». The Virtual Mentor. 8 (8): 524–528. PMID 23234692. doi:10.1001/virtualmentor.2006.8.8.pfor1-0608
James M (junho de 1996). «Isotretinoin for severe acne». Lancet. 347 (9017): 1749–50. PMID 8656912. doi:10.1016/S0140-6736(96)90814-4
David M, Hodak E, Lowe NJ (1988). «Adverse effects of retinoids». Medical Toxicology and Adverse Drug Experience. 3 (4): 273–88. PMID 3054426. doi:10.1007/bf03259940
DiGiovanna JJ (novembro de 2001). «Isotretinoin effects on bone». Journal of the American Academy of Dermatology. 45 (5): S176-82. PMID 11606950. doi:10.1067/mjd.2001.113721
Ellis CN, Madison KC, Pennes DR, Martel W, Voorhees JJ (1984). «Isotretinoin therapy is associated with early skeletal radiographic changes». Journal of the American Academy of Dermatology. 10 (6): 1024–9. PMID 6588057. doi:10.1016/S0190-9622(84)80329-1
Moy A, McNamara NA, Lin MC (setembro de 2015). «Effects of Isotretinoin on Meibomian Glands». Optometry and Vision Science. 92 (9): 925–30. PMID 26154692. doi:10.1097/OPX.0000000000000656
Lambert RW, Smith RE (março de 1989). «Effects of 13-cis-retinoic acid on the hamster meibomian gland». The Journal of Investigative Dermatology. 92 (3): 321–5. PMID 2918239. doi:10.1111/1523-1747.ep12277122
Fraunfelder FT, Fraunfelder FW, Edwards R (setembro de 2001). «Ocular side effects possibly associated with isotretinoin usage». American Journal of Ophthalmology. 132 (3): 299–305. PMID 11530040. doi:10.1016/S0002-9394(01)01024-8
Brelsford M, Beute TC (setembro de 2008). «Preventing and managing the side effects of isotretinoin». Seminars in Cutaneous Medicine and Surgery. 27 (3): 197–206. PMID 18786498. doi:10.1016/j.sder.2008.07.002
Scheinfeld N, Bangalore S (maio de 2006). «Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin». Journal of Drugs in Dermatology. 5 (5): 467–8. PMID 16703787
Leyden JJ, Del Rosso JQ, Baum EW (fevereiro de 2014). «The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions». The Journal of Clinical and Aesthetic Dermatology. 7 (2 Suppl): S3–S21. PMC 3970835. PMID 24688620
Bremner JD, Shearer KD, McCaffery PJ (janeiro de 2012). «Retinoic acid and affective disorders: the evidence for an association». The Journal of Clinical Psychiatry (Systematic Review). 73 (1): 37–50. PMC 3276716. PMID 21903028. doi:10.4088/JCP.10r05993
Kontaxakis VP, Skourides D, Ferentinos P, Havaki-Kontaxaki BJ, Papadimitriou GN (janeiro de 2009). «Isotretinoin and psychopathology: a review». Annals of General Psychiatry. 8. 2 páginas. PMC 2637283. PMID 19154613. doi:10.1186/1744-859X-8-2
Borovaya A, Olisova O, Ruzicka T, Sárdy M (setembro de 2013). «Does isotretinoin therapy of acne cure or cause depression?». International Journal of Dermatology. 52 (9): 1040–52. PMID 23962262. doi:10.1111/ijd.12169
Goodfield MJ, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD (junho de 2010). «Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010». The British Journal of Dermatology. 162 (6): 1172–9. PMID 21250961. doi:10.1111/j.1365-2133.2010.09836.x
Ludot M, Mouchabac S, Ferreri F (junho de 2015). «Inter-relationships between isotretinoin treatment and psychiatric disorders: Depression, bipolar disorder, anxiety, psychosis and suicide risks». World Journal of Psychiatry. 5 (2): 222–7. PMC 4473493. PMID 26110123. doi:10.5498/wjp.v5.i2.222
Wysowski DK, Pitts M, Beitz J (outubro de 2001). «An analysis of reports of depression and suicide in patients treated with isotretinoin». Journal of the American Academy of Dermatology. 45 (4): 515–9. PMID 11568740. doi:10.1067/mjd.2001.117730
Rowe C, Spelman L, Oziemski M, Ryan A, Manoharan S, Wilson P, Daubney M, Scott J (maio de 2014). «Isotretinoin and mental health in adolescents: Australian consensus». The Australasian Journal of Dermatology (Review). 55 (2): 162–7. PMID 24283385. doi:10.1111/ajd.12117
Palha JA, Goodman AB (junho de 2006). «Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia» (PDF). Brain Research Reviews. 51 (1): 61–71. PMID 16325258. doi:10.1016/j.brainresrev.2005.10.001 |hdl-access= requer |hdl= (ajuda)
Goodman AB (março de 1994). «Retinoid dysregulation as a cause of schizophrenia». The American Journal of Psychiatry. 151 (3): 452–3. PMID 8109664. doi:10.1176/ajp.151.3.452b
Goodman AB (maio de 1996). «Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology». Schizophrenia Research. 19 (2–3): 163–70. PMID 8789914. doi:10.1016/0920-9964(96)88523-9
Goodman AB (julho de 2005). «Microarray results suggest altered transport and lowered synthesis of retinoic acid in schizophrenia». Molecular Psychiatry. 10 (7): 620–1. PMID 15838536. doi:10.1038/sj.mp.4001668
Samad TA, Krezel W, Chambon P, Borrelli E (dezembro de 1997). «Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family». Proceedings of the National Academy of Sciences of the United States of America. 94 (26): 14349–54. Bibcode:1997PNAS...9414349S. PMC 24972. PMID 9405615. doi:10.1073/pnas.94.26.14349
Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD (setembro de 2010). «Isotretinoin use and the risk of inflammatory bowel disease: a case-control study». The American Journal of Gastroenterology. 105 (9): 1986–93. PMC 3073620. PMID 20354506. doi:10.1038/ajg.2010.124
Lowenstein EB, Lowenstein EJ (2011). «Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero». Clinics in Dermatology. 29 (6): 652–61. PMID 22014987. doi:10.1016/j.clindermatol.2011.08.026
Kremer I, Gaton DD, David M, Gaton E, Shapiro A (1994). «Toxic effects of systemic retinoids on meibomian glands». Ophthalmic Research. 26 (2): 124–8. PMID 8196934. doi:10.1159/000267402
Griffin JN, Pinali D, Olds K, Lu N, Appleby L, Doan L, Lane MA (novembro de 2010). «13-Cis-retinoic acid decreases hypothalamic cell number in vitro». Neuroscience Research. 68 (3): 185–90. PMID 20708044. doi:10.1016/j.neures.2010.08.003
Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery P (abril de 2004). «13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice». Proceedings of the National Academy of Sciences of the United States of America. 101 (14): 5111–6. Bibcode:2004PNAS..101.5111C. JSTOR 3371827. PMC 387382. PMID 15051884. doi:10.1073/pnas.0306336101
Sakai Y, Crandall JE, Brodsky J, McCaffery P (junho de 2004). «13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice». Annals of the New York Academy of Sciences. 1021 (1): 436–40. Bibcode:2004NYASA1021..436S. PMID 15251924. doi:10.1196/annals.1308.059
Nelson AM, Cong Z, Gilliland KL, Thiboutot DM (setembro de 2011). «TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells». The British Journal of Dermatology. 165 (3): 526–33. PMC 3166444. PMID 21564055. doi:10.1111/j.1365-2133.2011.10392.x
Nelson AM, Gilliland KL, Cong Z, Thiboutot DM (outubro de 2006). «13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes». The Journal of Investigative Dermatology. 126 (10): 2178–89. PMID 16575387. doi:10.1038/sj.jid.5700289
Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM (abril de 2008). «Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells». The Journal of Clinical Investigation. 118 (4): 1468–78. PMC 2262030. PMID 18317594. doi:10.1172/JCI33869
Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, Butkus D, Arnaud-Battandier J (fevereiro de 1979). «Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid». The New England Journal of Medicine. 300 (7): 329–33. PMID 153472. doi:10.1056/NEJM197902153000701
Shalita A (2001). «The integral role of topical and oral retinoids in the early treatment of acne». Journal of the European Academy of Dermatology and Venereology. 15: 43–9. PMID 11843233. doi:10.1046/j.0926-9959.2001.00012.x
Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E (junho de 2001). «Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation». Proceedings of the National Academy of Sciences of the United States of America. 98 (12): 6662–7. Bibcode:2001PNAS...98.6662P. JSTOR 3055868. PMC 34517. PMID 11371621. doi:10.1073/pnas.111464998
Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M (junho de 2002). «Sebaceous glands in acne patients express high levels of neutral endopeptidase». Experimental Dermatology. 11 (3): 241–7. PMID 12102663. doi:10.1034/j.1600-0625.2002.110307.x
Wysowski DK, Swartz L (maio de 2005). «Relationship between headache and depression in users of isotretinoin». Archives of Dermatology (em inglês). 141 (5): 640–1. PMID 15897395. doi:10.1001/archderm.141.5.640
Magin P, Pond D, Smith W (fevereiro de 2005). «Isotretinoin, depression and suicide: a review of the evidence». The British Journal of General Practice (em inglês). 55 (511): 134–8. PMC 1463189. PMID 15720936
Ng CH, Schweitzer I (fevereiro de 2003). «The association between depression and isotretinoin use in acne». The Australian and New Zealand Journal of Psychiatry (em inglês). 37 (1): 78–84. PMID 12534661. doi:10.1046/j.1440-1614.2003.01111.x
Centers for Disease Control Prevention (CDC) (janeiro de 2000). «Accutane-exposed pregnancies--California, 1999» (PDF). MMWR. Morbidity and Mortality Weekly Report. 49 (2): 28–31. PMID 10680601
Choi JS, Koren G, Nulman I (março de 2013). «Pregnancy and isotretinoin therapy». CMAJ. 185 (5): 411–413. PMC 3602257. PMID 23296582. doi:10.1503/cmaj.120729
Halverstam CP, Zeichner J, Lebwohl M (2006). «Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature». Journal of Cutaneous Medicine and Surgery. 10 (6): 291–9. PMID 17241599. doi:10.2310/7750.2006.00065

nytimes.com

«Anti-Acne Drug Faulted in Birth Defects». The New York Times. 22 de abril de 1988. Consultado em 2 de dezembro de 2022

pharmalive.com

Silverman E (4 de novembro de 2011). «It's Curtains On Actor's Accutane Lawsuit». Pharmalot. UBM Canon ^{[ligação inativa]}

publishing.service.gov.uk

assets.publishing.service.gov.uk

«Drug Safety Update – Latest advice for medicines users – October 2017» (PDF). Medicines and Healthcare products Regulatory Agency. 3 de outubro de 2017. Consultado em 17 de maio de 2019

uminho.pt

repositorium.sdum.uminho.pt

Palha JA, Goodman AB (junho de 2006). «Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia» (PDF). Brain Research Reviews. 51 (1): 61–71. PMID 16325258. doi:10.1016/j.brainresrev.2005.10.001 |hdl-access= requer |hdl= (ajuda)

washingtonpost.com

«FDA Eyes Ban on Acne Drug». Washington Post. 23 de abril de 1988. Consultado em 14 de novembro de 2022
«Roche Found Liable in First Of 400 Suits Over Accutane». The Washington Post. Bloomberg News. 30 de maio de 2007. Consultado em 30 de abril de 2012

web.archive.org

«iPledge (About iPledge)». Consultado em 20 de fevereiro de 2011. Arquivado do original em 29 de julho de 2017
«Fresh call for GPs to prescribe Roaccutane». AustralianDoctor. 19 de junho de 2012. Consultado em 7 de fevereiro de 2014. Cópia arquivada em 12 de abril de 2017
«Isotretinoin 20mg capsules - - (eMC)». www.medicines.org.uk. Consultado em 27 de dezembro de 2017. Arquivado do original em 28 de dezembro de 2017
«Isotretinoin 20mg capsules - - (eMC)». www.medicines.org.uk. Consultado em 10 de janeiro de 2018. Arquivado do original em 28 de dezembro de 2017
«Isotretinoin's Mechanism of Action Elucidated». Medconnect. Elsevier Global Medical News. 28 de agosto de 2009. Consultado em 13 de novembro de 2010. Cópia arquivada em 4 de abril de 2010
«Roche Discontinues and Plans to Delist Accutane in the U.S.» (Nota de imprensa). Genentech. 29 de junho de 2009. Consultado em 12 de novembro de 2010. Arquivado do original em 8 de novembro de 2009

zenodo.org

Brelsford M, Beute TC (setembro de 2008). «Preventing and managing the side effects of isotretinoin». Seminars in Cutaneous Medicine and Surgery. 27 (3): 197–206. PMID 18786498. doi:10.1016/j.sder.2008.07.002
Wysowski DK, Pitts M, Beitz J (outubro de 2001). «An analysis of reports of depression and suicide in patients treated with isotretinoin». Journal of the American Academy of Dermatology. 45 (4): 515–9. PMID 11568740. doi:10.1067/mjd.2001.117730